MONOCLONAL-ANTIBODY 17-1A (MAB) ADJUVANT THERAPY OF RESECTED DUKES-C COLORECTAL-CARCINOMA (CRC) - A COST-EFFECTIVENESS ANALYSIS IN GERMANY

Authors
SCHADLICH PK LUTZELBERGER U BRECHT JG VOLMER T
Citation
Pk. Schadlich et al., MONOCLONAL-ANTIBODY 17-1A (MAB) ADJUVANT THERAPY OF RESECTED DUKES-C COLORECTAL-CARCINOMA (CRC) - A COST-EFFECTIVENESS ANALYSIS IN GERMANY, Annals of oncology, 9, 1998, pp. 198-198
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
4
Pages
198 - 198
Database
ISI
SICI code
0923-7534(1998)9:<198:M1(ATO>2.0.ZU;2-3